Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.

Fu, Zhong-Chao; Cheng, Xiao-Gui; Zhang, Guo-Wen; Shi, Ran-Geng; Zhang, Li-Jun; Sun, Hai-Tian; Huang, Jin-Xian

Fu, Zhong-Chao; Cheng, Xiao-Gui; Zhang, Guo-Wen; Shi, Ran-Geng; Zhang, Li-Jun; Sun, Hai-Tian; Huang, Jin-Xian.

Afiliación

Fu ZC; Division of Rheumatology, Department of Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Cheng XG; Department of Pharmacy, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Zhang GW; Department of Pathological Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Shi RG; Division of Rheumatology, Department of Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Zhang LJ; Department of Pathological Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Sun HT; Special Inspection Project Department, Guangzhou Huayin Medical Examination Center, Guangzhou, Guangdong, China.
Huang JX; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.

Int J Rheum Dis ; 27(5): e15190, 2024 May.

Article en En | MEDLINE | ID: mdl-38736279

Asunto(s)

Adalimumab; Espondiloartritis Axial; Biosimilares Farmacéuticos; Humanos; Adalimumab/uso terapéutico; Biosimilares Farmacéuticos/uso terapéutico; Biosimilares Farmacéuticos/efectos adversos; Estudios Retrospectivos; China/epidemiología; Femenino; Masculino; Resultado del Tratamiento; Adulto; Espondiloartritis Axial/diagnóstico; Espondiloartritis Axial/inmunología; Espondiloartritis Axial/tratamiento farmacológico; Antirreumáticos/uso terapéutico; Persona de Mediana Edad; Inhibidores del Factor de Necrosis Tumoral/uso terapéutico; Inhibidores del Factor de Necrosis Tumoral/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Adalimumab / Espondiloartritis Axial Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Rheum Dis Asunto de la revista: REUMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google